A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer (Q33265964)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer |
scientific article |
Statements
1 reference
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer (English)
1 reference
Helmut Friess
1 reference
Jan M Langrehr
1 reference
Helmut Oettle
1 reference
Jochen Raedle
1 reference
Christian Dittrich
1 reference
Dieter K Hossfeld
1 reference
Herbert Stöger
1 reference
Bart Neyns
1 reference
Peter Herzog
1 reference
Pascal Piedbois
1 reference
Frank Dobrowolski
1 reference
Werner Scheithauer
1 reference
Robert Hawkins
1 reference
Frieder Katz
1 reference
Peter Balcke
1 reference
Jan Vermorken
1 reference
Simon van Belle
1 reference
Neville Davidson
1 reference
Albert Abad Esteve
1 reference
Daniel Castellano
1 reference
Jörg Kleeff
1 reference
Adrien A Tempia-Caliera
1 reference
Andreas Kovar
1 reference
Johannes Nippgen
1 reference
11 December 2006
1 reference
1 December 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference